Иммунитет против ВИЧ: почему «выборчивость» работает лучше, чем широкая защита

Анализ данных UK Biobank показал, что механизмы защиты от грибковых инфекций могут быть неэффективны против ВИЧ. Исследователи выяснили, что для борьбы с вирусом более полезны специализированные молекулы HLA-II, игнорирующие большинство пептидов, в отличие от широкого распознавания, необходимого при других угрозах.

Перевод ИИ

Текст статьи доступен на языке оригинала.

Нажмите кнопку «Перевести статью» выше, чтобы сгенерировать перевод с помощью ИИ.

Оригинальный контент

Источник

The human immune system identifies "foreign" proteins, but its recognition process is highly selective. The conventional wisdom suggests that a broader repertoire of pathogen recognition equates to greater overall immunity. However, a recent analysis of hundreds of thousands of participants in the UK Biobank has uncovered a puzzling disparity: the very mechanisms that provide protection against fungal and respiratory infections may be ineffective, or even detrimental, when facing HIV. This crucial recognition process is orchestrated by human leukocyte antigen (HLA) class II molecules. These molecules function as display windows, capturing fragments of pathogens, known as peptides, and presenting them to T-helper cells. In turn, these T-helper cells signal B-lymphocytes to produce antibodies. The genetic makeup of an individual dictates the "width" of this display window—that is, the specific peptides that a particular HLA-II molecule can bind and showcase. Research published in Nature Communications categorizes the effectiveness of these molecules into two distinct scenarios: Biophysicist Alexey Kornilov explains that the specificity of peptide binding determines the signals the immune system receives about an enemy. A molecule that is too selective might miss certain antigens, thereby delaying the initiation of a protective response. The paradox presented by HIV suggests that for certain viruses, the "see everything" strategy is counterproductive. In these cases, highly specialized molecules that ignore most peptides prove more effective in combating a specific pathogen. This finding clarifies why individuals with different HLA-II genetic profiles exhibit varying responses to the same threats. However, the data remains insufficient to explain precisely why this "pickiness" confers protection against HIV, while a broad recognition capacity is essential for combating fungal and skin infections. Source: This commentary was adapted from an original Russian-language publication by Pravda.Ru. Subscribe to Pravda.Ru Telegram channel, Facebook, RSS!